PGK1, the first ATP-generating enzyme in glycolysis, gradually increased in ESCC progression in all 6 tracks at the protein level and identified as the nominated drug-targetable protein in ESCC progression (Supplementary Fig. 8a). This evidence concerns the gene PGK1 and esophageal squamous cell carcinoma.